paxilline has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horinouchi, W; Imagawa, M; Nishizuka, M; Ochiai, N; Osada, S; Yamada, E | 1 |
| Booth, FW; Carson, JA; Flück, M; Gordon, SE; Ziemiecki, A | 1 |
2 other study(ies) available for paxilline and Hypertrophy
| Article | Year |
|---|---|
KCNMA1, a pore-forming α-subunit of BK channels, regulates insulin signalling in mature adipocytes.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue, White; Animals; Cell Differentiation; Gene Expression Regulation; Gene Knockdown Techniques; Hypertrophy; Indoles; Insulin; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2016 |
Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle.
Topics: Animals; Cell Adhesion Molecules; Chickens; Cytoskeletal Proteins; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Hypertrophy; Male; Muscle, Skeletal; Osmolar Concentration; Paxillin; Phosphoproteins; Physical Stimulation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1999 |